Treatment of Candida nail infection with terbinafine

Journal of the American Academy of Dermatology

Volumn 35, Issue 6, 1996, Pages 958-961

  Segal, Rina ^a   Kritzman, Aharon ^a   Cividalli, Lia ^a,b   Samra, Zmira ^a,b   David, Michael ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TERBINAFINE;

ADULT; ARTICLE; CANDIDA PARAPSILOSIS; CANDIDIASIS; CLINICAL ARTICLE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; HUMAN; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029752998     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90120-6     Document Type: Article

References (12)

1. Hay RJ, Baran R, Moore MH, et al. Candida onychomycosis: an evaluation of the role of Candida species in nail disease. Br J Dermatol 1988;118:47-58.
2. Willemsen M. Changing patterns in superficial infections: focus on onychomycosis. J Eur Acad Dermatol Venereol 1993;2(suppl):S6-S11.
3. Clayton YM. Clinical and mycological diagnostic aspects of onychomycosis and dermatomycoses. Clin Exp Dermatol 1992;17(suppl 1):37-40.
4. Budak A, Macura AB, Mazur T, et al. Fungal species isolated from skin and nail of hands and feet of patients suspected of mycotic infection. Mykosen 1987;30:434-9.
5. Balfour JA, Faulds D. Terbinafine, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in superficial mycoses. Drugs 1992;43:258-84.
6. Shadomy S, Espinel I, Groff A, et al. In vitro studies with SF 86-327: a new orally active allylamine derivative. Sabouraud 1985;23:125-32.
7. Clayton YM. In vitro activity of terbinafine. Clin Exp Dermatol 1989;14:101-3.
8. Goodfield MJD. Short duration therapy with terbinafine for dermatophyte onychomycosis: a multicenter trial. Br J Dermatol 1992;126 (suppl 29):33-5.
9. Roberts DT, Richardson MD, Dwyer PK, et al. Terbinafine in chronic paronychia and Candida onychomycosis. J Dermatol Treat 1992;3(suppl 1):38-42.
10. Nolting S, Brautigam M, Weidinger G. Terbinafine in onychomycosis with involvement by nondermatophy tic fungi. Br J Dermatol 1994;130(suppl 43):16-21.
11. Faergemann J, Zehender H, Millerioux L. Levels of terbinafine in plasma, str. corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally and daily for 7 and 14 days. Clin Exp Dermatol 1994;19:121-6.
12. Finlay AY. Pharmacokinetics of terbinafine in the nail. Br J Dermatol 1992;126(suppl 39):28-32.